AllianceBernstein’s LifeMD LFMD Stock Holding History

AllianceBernstein’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	63,960 +19,200	+43%	+$84.7K	﹤0.01%	3102
2026 Q1	$153K	Hold	44,760	–	–	﹤0.01%	3106
2025 Q4	$153K	Hold	44,760	–	–	﹤0.01%	3114
2025 Q3	$304K	Hold	44,760	–	–	﹤0.01%	2936
2025 Q2	$610K	Buy	44,760 +27,300	+156%	+$258K	﹤0.01%	2526
2025 Q1	$95K	Hold	17,460	–	–	﹤0.01%	3074
2024 Q4	$86.4K	Hold	17,460	–	–	﹤0.01%	3138
2024 Q3	$91.5K	Hold	17,460	–	–	﹤0.01%	3142
2024 Q2	$120K	Buy	+17,460	New	+$160K	﹤0.01%	3101
2021 Q3	–	Sell	-53,266	Closed	-$627K	–	3318
2021 Q2	$627K	Buy	+53,266	New	+$613K	﹤0.01%	2723

Other funds holding LFMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

AllianceBernstein's LFMD Position: Q2 2026 in Review

AllianceBernstein increased its LifeMD (LFMD) stake by 43% in Q2 2026, buying an estimated $84.7K and bringing the position to 63,960 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

AllianceBernstein first reported a position in LFMD in Q2 2021 and has held it in 10 quarters since. The position peaked at $627K in Q2 2021. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

AllianceBernstein held 63,960 shares of LifeMD worth $231K as of Q2 2026.
AllianceBernstein bought 19,200 LifeMD shares in Q2 2026, an estimated $84.7K.
LifeMD made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3102 holding.
AllianceBernstein first reported a position in LifeMD in Q2 2021 and has held it in 10 quarters since.
AllianceBernstein's LifeMD position peaked at $627K in Q2 2021.
116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.